U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    Cd80 Cd80 molecule [ Rattus norvegicus (Norway rat) ]

    Gene ID: 25408, updated on 9-Dec-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    Losartan Protects Podocytes against High Glucose-induced Injury by Inhibiting B7-1 Expression.

    Losartan Protects Podocytes against High Glucose-induced Injury by Inhibiting B7-1 Expression.
    Gao H, Du WY, Lin J, Han SL, Zhang YJ, Sun XF.

    12/25/2021
    Diabetes-Mediated Toxicity Resulted in the Expression of CD80 and CD86 on Neutrophils after Delayed Wound Healing in Male Rats.

    Diabetes-Mediated Toxicity Resulted in the Expression of CD80 and CD86 on Neutrophils after Delayed Wound Healing in Male Rats.
    Ebaid H, Abdel-Salam B, Hassan I, Al-Tamimi J, Metwalli A, Rady A, Alhazza IM., Free PMC Article

    04/17/2021
    ETRA antagonist restores podocyte foot process effacement as well as the aberrant expression of TLR-3, nuclear factor-kappaB (NF-kappaB), and CD80 in puromycin aminonucleoside-injured kidneys

    Antiproteinuric effect of an endothelin-1 receptor antagonist in puromycin aminonucleoside-induced nephrosis in rat.
    Kino J, Tsuji S, Kitao T, Akagawa Y, Yamanouchi S, Kimata T, Kaneko K.

    08/17/2019
    Selective expression of B7-1 (CD80) is important and may serve as a guide for future therapies aimed at transplant tolerance.

    HLA-G-treated tolerogenic dendritic cells induce tolerogenic potential by increasing expression of B7-1 (CD80) molecules.
    Smith M, Bittner JG 4th, White S, Smith D, Horuzsko A.

    01/21/2010
    Blocking expression of B7.1 in donor spleens by antisense gene therapy represents a potential alloantigen-specific immunosuppressive strategy to inhibit acute rejection against splenic allografts.

    Gene transfer of antisense B7.1 attenuates acute rejection against splenic allografts in rats.
    Liu C, Pan S, Jiang H, Sun X.

    01/21/2010
    Upregulation of B7.1 with the downregulation of GLEPP1, Wilms' tumor gene (WT1), megalin, and vascular endothelial growth factor started early and persisted through the course of rimary glomerular disease.

    Early changes in gene expression that influence the course of primary glomerular disease.
    Clement LC, Liu G, Perez-Torres I, Kanwar YS, Avila-Casado C, Chugh SS.

    01/21/2010
    B7.1 and B7.2 are expressed in the eye at different times during experimental autoimmune anterior uveitis. Both B7 molecules are required for the induction of EAAU, although they probably have different roles.

    Expression of B7 molecules in the eye during experimental autoimmune anterior uveitis (EAAU).
    Shao H, Sun D, Sun SL, Cruze JM, Bora N, Kaplan HJ.

    01/21/2010
    CTLA4Ig gene therapy is a successful strategy for the prevention of allogeneic graft rejection in corneal transplantation. Our work has further elucidated the mechanisms of corneal allograft rejection which may lead to novel therapeutic strategies.

    Influence of local and systemic CTLA4Ig gene transfer on corneal allograft survival.
    Gong N, Pleyer U, Yang J, Vogt K, Hill M, Anegon I, Volk HD, Ritter T.

    01/21/2010
    Differential effect of CD28 versus B7 blockade on direct pathway of allorecognition and self-restricted responses.

    Differential effect of CD28 versus B7 blockade on direct pathway of allorecognition and self-restricted responses.
    Haspot F, Villemain F, Laflamme G, Coulon F, Olive D, Tiollier J, Soulillou JP, Vanhove B.

    01/21/2010
    an inducible diabetes model in transgenic mice based on rat insulin promotor (RIP)-driven expression of CD80 (B7-1) on pancreatic beta cells.

    Cytotoxic T cell-mediated diabetes in RIP-CD80 transgenic mice: autoantigen peptide sensitivity and fine specificity.
    Pechhold K, Chakrabarty S, Harlan DM.

    01/21/2010
    Upregulation of B7-1 in induced Minimal change-like nephropathy.

    Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats.
    Lai KW, Wei CL, Tan LK, Tan PH, Chiang GS, Lee CG, Jordan SC, Yap HK.

    01/21/2010
    Chondrogenic differentiation may increase the immunogenicity of mesenchymal stem cells, leading to stimulation of dendritic cells and upregulation of B7 molecules may be partially responsible for this event.

    Chondrogenic differentiation alters the immunosuppressive property of bone marrow-derived mesenchymal stem cells, and the effect is partially due to the upregulated expression of B7 molecules.
    Chen X, McClurg A, Zhou GQ, McCaigue M, Armstrong MA, Li G.

    01/21/2010
    firstprevious page of 1 nextlast